March 28, 2024 12:04 PM | 2 minute read |
This 141-year-old retailer outperforms Amazon
Forget about big tech companies. This old stock is expanding rapidly while increasing its dividend. Believe it or not, the company has easily beaten Amazon’s stock price by 117% since 2019. Read Benzinga’s latest insider-only report to set yourself up for future profits, income, and more with this stock.Get access for just $0.99.
focused on hemp CV Science Co., Ltd. (OTCQB:CVSI) announced. Financial results for the year ending December 31, 2023 will be announced on Thursday.
The San Diego-based company reported: Gross profit margin for fiscal 2023 was 44.3%, an improvement from 34.2% in fiscal 2022. Gross margin for the fourth quarter was 45.8%, continuing to improve from 45.1% in the third quarter.
Enter to win $500 in stocks or crypto
Enter your email address to get Benzinga’s Ultimate Morning Update, a free $30 gift card, and more.
“Our progress in 2023 demonstrates our continued commitment to innovation and cost-effective execution as we move closer to profitability and positive cash flow.” joseph dowling The CEO of CV Science said: “As the CBD category strengthens, we have expanded our market share across key distribution channels, including the natural products retail channel. will continue to focus resources on new product development. Chew for hip and joint health and calming care. ”
With earnings season over, 2023 financial performance and 2024 outlook are sure to be among the many topics of conversation at the Benzinga Cannabis Capital Conference, which returns to Florida on April 16-17. . The two-day event will be held at The Diplomat Beach Resort It’s an opportunity for entrepreneurs big and small to network, learn, and grow.
SEE ALSO: Capitalizing on the plant-based trend: Cultured food acquisition allows this US hemp company to expand in Europe
Free Report: How to Learn Options Trading Quickly
In this special report, you’ll learn the 4 best options trading strategies, how to stay safe as a complete beginner, a 411% trading case study, and how to access two new winning options trades starting today. Learn.Request your free report here.
FY2023 Financial Highlights
- Revenues totaled $16 million, In 2022, it is $16.2 million.
- Total profit reached $7 million, That’s up from $5.5 million the previous year.
- Total operating expenses were $3.7 million, down from $12.4 million in 2022.
- Net income attributable to common stockholders was $3.1 million, compared to a net loss of $9.1 million in the prior year.
- Adjusted EBITDA was negative by $2.3 million compared to 2022 adjusted EBITDA loss of $6.1 million.
- The Company’s total current assets were $9.2 million as of December 31, 2023, compared to $12.7 million as of December 31, 2023.
- Total debt was $6.3 million, down from $13.5 million a year ago.
related news
CVSI price action
CV Science Co., Ltd. The stock traded 1.48% lower at $0.0384 per share. As of this writing Thursday morning.
of Benzinga Cannabis Capital Conference returns to Florida on April 16 and 17, 2024 at a new venue in Hollywood. His two-day event at The Diplomat Beach Resort It’s an opportunity for entrepreneurs big and small to network, learn, and grow. Known for its ability to set trends and influence the future of cannabis, this conference is the cannabis world’s most anticipated event of the year. Please mark your calendars.
Get your tickets now bzcannabis.com – Prices will increase soon.
This 141-year-old retailer outperforms Amazon
Forget about big tech companies. This old stock is expanding rapidly while increasing its dividend. Believe it or not, the company has easily beaten Amazon’s stock price by 117% since 2019. Read Benzinga’s latest insider-only report to set yourself up for future profits, income, and more with this stock.Get access for just $0.99.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
